Lal Nand, Jangir Santosh, Bala Veenu, Mandalapu Dhanaraju, Sarswat Amit, Kumar Lalit, Jain Ashish, Kumar Lokesh, Kushwaha Bhavana, Pandey Atindra K, Krishna Shagun, Rawat Tara, Shukla Praveen K, Maikhuri Jagdamba P, Siddiqi Mohammad I, Gupta Gopal, Sharma Vishnu L
Medicinal & Process Chemistry Division, CSIR-Central Drug Research Institute, Lucknow, 226031, India.
Medicinal & Process Chemistry Division, CSIR-Central Drug Research Institute, Lucknow, 226031, India; Academy of Scientific & Innovative Research (AcSIR), New Delhi, 110001, India.
Eur J Med Chem. 2016 Jun 10;115:275-90. doi: 10.1016/j.ejmech.2016.03.012. Epub 2016 Mar 9.
Trichomoniasis and candidiasis are amongst the most common morbidity-causing reproductive tract infections, generally treated by Metronidazole and Fluconazole respectively. Poor vaginal efficacy, drug-resistance and non-spermicidal nature limit their use as topical microbicidal contraceptives. Bis(dialkylaminethiocarbonyl)disulfides (4-38) were designed as dually active, non-surfactant molecules capable of eliminating Trichomonas vaginalis and Candida strains as well as irreversibly immobilizing 100% human sperm instantly, at doses non-cytotoxic to human cervical epithelial cells and vaginal microflora in vitro. Compounds 12, 16, 17 were fifty times more active than nonoxynol-9, OTC vaginal spermicide, and compounds 12 and 17 have shown remarkable in vivo activity in rabbit model. Most promising compound 17 has shown promise for further development as a double-edged vaginal microbicide due to their improved activity and safety along with notable in vivo trichomonicidal activity. Role of disulfide group was established by loss of spermicidal activity on chemical modifications (39-56). These disulfides might be targeting thiol groups present over cell membrane of human sperm and Trichomonas as shown by fluorescence labeling of free thiols.
滴虫病和念珠菌病是最常见的引起生殖道感染的疾病,通常分别用甲硝唑和氟康唑治疗。较差的阴道疗效、耐药性和无杀精特性限制了它们作为局部杀微生物避孕药的使用。双(二烷基氨基甲酰基)二硫化物(4-38)被设计为具有双重活性的非表面活性剂分子,能够消除阴道毛滴虫和念珠菌菌株,并能立即不可逆地使100%的人类精子失活,其剂量在体外对人宫颈上皮细胞和阴道微生物群无细胞毒性。化合物12、16、17的活性比非诺考9(一种非处方阴道杀精剂)高50倍,化合物12和17在兔模型中显示出显著的体内活性。最有前景的化合物17由于其活性和安全性的提高以及显著的体内杀滴虫活性,有望进一步开发成为一种双刃阴道杀微生物剂。通过化学修饰(39-56)导致杀精活性丧失,确定了二硫键的作用。如游离硫醇的荧光标记所示,这些二硫化物可能靶向人类精子和阴道毛滴虫细胞膜上存在的硫醇基团。